 
                Lv4
506 积分 2023-08-23 加入
为高质量的临床试验而奋斗,为改变临床实践而奋斗,为医药进步和患者健康而奋斗~
 High HPK1+PD-1+TIM-3+CD8+ T cells infiltration predicts poor prognosis to immunotherapy in NSCLC patients
                                            6小时前
                                            待确认
High HPK1+PD-1+TIM-3+CD8+ T cells infiltration predicts poor prognosis to immunotherapy in NSCLC patients
                                            6小时前
                                            待确认
                                         Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy
                                            6小时前
                                            待确认
Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy
                                            6小时前
                                            待确认
                                         Opportunities and challenges for targeting HPK1 in cancer immunotherapy
                                            9小时前
                                            已完结
Opportunities and challenges for targeting HPK1 in cancer immunotherapy
                                            9小时前
                                            已完结
                                         Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
                                            21天前
                                            已完结
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
                                            21天前
                                            已完结
                                         Nutritional management of gastric cancer
                                            5个月前
                                            已完结
Nutritional management of gastric cancer
                                            5个月前
                                            已完结
                                         A systematic examination of anti-drug antibody titer estimation: Applied recommendations
                                            8个月前
                                            已完结
A systematic examination of anti-drug antibody titer estimation: Applied recommendations
                                            8个月前
                                            已完结
                                         A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
                                            11个月前
                                            已完结
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
                                            11个月前
                                            已完结
                                         An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin’s lymphoma
                                            1年前
                                            已完结
An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin’s lymphoma
                                            1年前
                                            已完结
                                         An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin’s lymphoma
                                            1年前
                                            已完结
An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin’s lymphoma
                                            1年前
                                            已完结
                                         Design Strategy and Consideration for Oncology Dose-Optimization: An Industry Perspective
                                            1年前
                                            已完结
Design Strategy and Consideration for Oncology Dose-Optimization: An Industry Perspective
                                            1年前
                                            已完结